AQST CMO reports 2,000 indirect shares on Form 3

Aquestive Therapeutics, Inc. filed an initial ownership report for Chief Medical Officer Matthew J. Greenhawt.

Rhea-AI Filing Summary

Aquestive Therapeutics, Inc. filed an initial ownership report for Chief Medical Officer Matthew J. Greenhawt. The filing shows indirect beneficial ownership of 2,000 shares of Common Stock held by his spouse. This Form 3 records an existing position and does not report any new purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Greenhawt Matthew J.

Role Chief Medical Officer

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 2,000 shares (Indirect, by spouse)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Aquestive Therapeutics (AQST) Form 3 for Matthew J. Greenhawt report?

The Form 3 reports that Chief Medical Officer Matthew J. Greenhawt has indirect beneficial ownership of 2,000 shares of Aquestive Therapeutics Common Stock held by his spouse, establishing his initial disclosed equity position as an insider.

Did Matthew J. Greenhawt buy or sell Aquestive Therapeutics (AQST) shares in this Form 3?

No new buy or sell transaction is reported. The Form 3 simply discloses an existing indirect holding of 2,000 Common Stock shares attributed to his spouse, serving as an initial ownership statement rather than a trade report.

How are the 2,000 Aquestive Therapeutics (AQST) shares held for Matthew J. Greenhawt?

The filing states the 2,000 shares of Common Stock are held indirectly by Matthew J. Greenhawt, with the nature of ownership described as "by spouse," meaning the shares are in his spouse’s name but reported as his beneficial ownership.

What is the significance of a Form 3 filing for Aquestive Therapeutics (AQST) insiders?

A Form 3 is an insider’s initial ownership report when they become a reporting person. It lists their existing shareholdings, like the 2,000 indirectly held shares here, creating a baseline for future Forms 4 or 5 showing subsequent transactions.

Does the Aquestive Therapeutics (AQST) Form 3 show any derivative securities for Matthew J. Greenhawt?

No derivative securities are listed in this Form 3. The filing only shows an indirect holding of 2,000 shares of Common Stock held by his spouse, with no options, warrants, or other derivative positions disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 09:19 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Greenhawt Matthew J.

(Last) (First) (Middle)

C/O AQUESTIVE THERAPEUTICS, INC.

30 TECHNOLOGY DRIVE

(Street)

WARREN NJ 07059

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/02/2026

3. Issuer Name and Ticker or Trading Symbol
Aquestive Therapeutics, Inc. [ AQST ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,000	I	by spouse

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Lori J. Braender, as Attorney-In-Fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.